Chronic constipation: new diagnostic and treatment approaches

被引:21
作者
Lacy, Brian E. [1 ]
Levenick, John M. [1 ]
Crowell, Michael [2 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Sect Gastroenterol & Hepatol, Lebanon, NH 03756 USA
[2] Mayo Clin, Dept Gastroenterol & Hepatol, Scotsdale, AZ USA
来源
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2012年 / 5卷 / 04期
关键词
anorectal manometry; constipation; guanylate cyclase; linaclotide; lubiprostone; plecanitide; prucalopride; Rome criteria; velusetrag; wireless motility capsule; GUANYLATE-CYCLASE-C; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DIRECT MEDICAL COSTS; INTESTINAL SECRETION; COLONIC TRANSIT; UNITED-STATES; HEALTH-CARE; LINACLOTIDE; DISORDERS;
D O I
10.1177/1756283X12443093
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic constipation is a highly prevalent disorder that affects approximately 15% of the US population. Chronic constipation refers to patients who have had symptoms for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation. This is best defined using the Rome III criteria, which involves an evaluation of stool frequency in addition to symptoms of straining, feelings of incomplete evacuation, and the need to use manual maneuvers to assist with stool evacuation. Symptoms can be burdensome, leading to a reduction in patients' quality of life. As a national healthcare issue, chronic constipation is also important because it imposes a significant economic impact on the healthcare system. A number of treatment options are currently available, both over-the-counter and by prescription, although not all patients respond to these therapies. This review will focus on new medical treatment options for the management of chronic constipation, and the safety and efficacy of these agents will be reviewed. In addition, the efficacy of new diagnostic tests to evaluate colonic motility and anorectal function are described.
引用
收藏
页码:233 / 247
页数:15
相关论文
共 50 条
  • [21] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Maria I. Vazquez-Roque
    Ernest P. Bouras
    Advances in Therapy, 2013, 30 : 203 - 211
  • [22] The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation
    Jeremy D. Gale
    Advances in Therapy, 2009, 26 : 519 - 530
  • [23] Diagnostic Approach to Chronic Constipation in Adults
    Jamshed, Namirah
    Lee, Zone-En
    Olden, Kevin W.
    AMERICAN FAMILY PHYSICIAN, 2011, 84 (03) : 299 - 306
  • [24] Update on the management of constipation in the elderly: new treatment options
    Rao, Satish S. C.
    Go, Jorge T.
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 163 - 171
  • [25] Emerging treatments for chronic constipation
    Gudsoorkar, Vineet S.
    Quigley, Eamonn M. M.
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (03) : 365 - 373
  • [26] Chronic constipation: overview and challenges
    Cook, I. J.
    Talley, N. J.
    Benninga, M. A.
    Rao, S. S.
    Scott, S. M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 : 1 - 8
  • [27] Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
    DeMicco, Michael
    Barrow, Laura
    Hickey, Bernadette
    Shailubhai, Kunwar
    Griffin, Patrick
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (11) : 837 - 851
  • [28] Review article: current and future treatment approaches for IBS with constipation
    Liu, Joy J.
    Brenner, Darren M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 : S53 - S62
  • [29] Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
    Islam, Bianca N.
    Sharman, Sarah K.
    Browning, Darren D.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2018, 11 : 323 - 330
  • [30] Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation
    Roque, Maria Vazquez
    Camilleri, Michael
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (03) : 301 - 310